Annual Report 2024

REPORT OF THE DIRECTORS 30 The United Laboratories International Holdings Limited Annual Report 2024 During the year ended 31 December 2024, the movements of unvested Awarded Shares granted under the Share Award Scheme are as follows: Number of unvested Awarded Shares Grantee name/categories Date of grant Vesting period As at 1 Jan 2024 Granted during the year Vested during the year Lapsed during the year Cancelled during the year As at 31 December 2024 Directors of the Company: Tsoi Hoi Shan 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 575,100 – 191,700 – – 383,400 Leung Wing Hon 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 401,100 – 133,700 – – 267,400 Choy Siu Chit 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 268,800 – 89,600 – – 179,200 Fang Yu Ping 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 186,900 – 62,300 – – 124,600 Zou Xian Hong 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 186,900 – 62,300 – – 124,600 Zhu Su Yan 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 186,900 – 62,300 – – 124,600 Other employees of the Group: 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 10,291,200 – 3,004,280 426,120 – 6,860,800 Total Awarded Shares granted: 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 12,096,900 – 3,606,180 426,120 – 8,064,600 Five highest paid individuals in aggregate (note 1) : 13 Nov 2023 13 Nov 2024 to 13 Nov 2026 1,618,800 – 539,600 – – 1,079,000 Notes: 1. All of the five highest paid individuals of the Group are directors of the Company. 2. There is no purchase price to be paid by the grantees. The consideration for each grant of the Awarded Shares in nil. 3. The closing prices of the shares of the Company immediate before the date of the grant and on the date of the grant of the unvested Awarded Shares were HK$7.77 and HK$7.45 per share respectively. 4. The fair value of the unvested Awarded Shares granted on 13 November 2023 was HK$7.45 per share as at the date of grant. 5. The accounting standard and policy adopted are set out in note 3 to the consolidated financial statements in 2024 Annual Report.